The Novo Nordisk company is stopping the production of human insulin pen-type insulin syringes, affecting people with type 1 diabetes.
Călin Nicolescu
Health
Foto Pixabay
Always see our news on Google
People with type 1 diabetes who depend on human insulin made by Novo Nordisk will instead be given glass vials and syringes - said to be inconvenient and harder to use with the same precision. Novo Nordisk has already stopped supply in South Africa, where patients have had to switch to glass vials. Novo Nordisk's decision is linked to its favoring of the marketing of the slimming drugs Ozempic and Wegovy.
Sources
O companie farmaceutică ar fi oprit producţia de seringi cu insulină pentru a vinde produse de slăbit
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
Novo Nordisk, compania producătoare de medicamente folosite pentru pierderea în greutate, acuzată că prioritizează profiturile după oprirea producției de stilouri cu insulină
Latest News
07:57
Unauthorized protest by farmers in Victory Square: They are prepared to stay several days in the capital and say they are not afraid of fines / Their demands
07:29
U.S. democracy indicators are at their lowest levels in the past 50 years / The decline of democracy in America is becoming a problem for Europe
07:19
2026 Emmy Awards: Matthew Rhys makes history with two Emmy trophies won on the same night / List of the main winners
07:16
North Korean leader Kim Jong Un promised continued support for Russia and described Moscow’s war against Ukraine as “sacred”
23:55
The US sanctions Russia’s second-largest bank / Washington accuses VTB Bank of helping Iran evade sanctions
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
